Trial
NCT05720988
Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Stemline Therapeutics, Inc.
Condition
Acute Myeloid Leukemia
Intervention
Azacitidine
Why stopped
trial was not opened
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-08